JP2011529942A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529942A5
JP2011529942A5 JP2011521561A JP2011521561A JP2011529942A5 JP 2011529942 A5 JP2011529942 A5 JP 2011529942A5 JP 2011521561 A JP2011521561 A JP 2011521561A JP 2011521561 A JP2011521561 A JP 2011521561A JP 2011529942 A5 JP2011529942 A5 JP 2011529942A5
Authority
JP
Japan
Prior art keywords
crystalline form
compound
formula
methylbenzenesulfonate
xrpd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011521561A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529942A (ja
Filing date
Publication date
Priority claimed from GBGB0814340.6A external-priority patent/GB0814340D0/en
Application filed filed Critical
Publication of JP2011529942A publication Critical patent/JP2011529942A/ja
Publication of JP2011529942A5 publication Critical patent/JP2011529942A5/ja
Withdrawn legal-status Critical Current

Links

JP2011521561A 2008-08-05 2009-08-04 ピリジン誘導体の結晶体 Withdrawn JP2011529942A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0814340.6A GB0814340D0 (en) 2008-08-05 2008-08-05 Anhydrous crystol form fo a pyridine derivative
GB0814340.6 2008-08-05
PCT/EP2009/060089 WO2010015626A1 (en) 2008-08-05 2009-08-04 Crystalline forms of a pyridine derivative

Publications (2)

Publication Number Publication Date
JP2011529942A JP2011529942A (ja) 2011-12-15
JP2011529942A5 true JP2011529942A5 (OSRAM) 2012-09-27

Family

ID=39767571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521561A Withdrawn JP2011529942A (ja) 2008-08-05 2009-08-04 ピリジン誘導体の結晶体

Country Status (14)

Country Link
US (1) US8093242B2 (OSRAM)
EP (1) EP2321324A1 (OSRAM)
JP (1) JP2011529942A (OSRAM)
KR (1) KR20110052686A (OSRAM)
CN (1) CN102171219A (OSRAM)
AU (1) AU2009279135B2 (OSRAM)
BR (1) BRPI0917224A2 (OSRAM)
CA (1) CA2733235A1 (OSRAM)
EA (1) EA201170300A1 (OSRAM)
GB (1) GB0814340D0 (OSRAM)
IL (1) IL210777A0 (OSRAM)
MX (1) MX2011001414A (OSRAM)
WO (1) WO2010015626A1 (OSRAM)
ZA (1) ZA201100426B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2772168C (en) 2009-08-27 2019-01-08 Glaxosmithkline Llc Anhydrate forms of a pyridine derivative
CN114272242A (zh) * 2015-05-18 2022-04-05 康堤医疗有限公司 用于治疗性激素依赖性疾病的双重nk-1/nk-3受体拮抗剂
CA3092238A1 (en) 2018-03-14 2019-09-19 KaNDy Therapeutics Limited Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists
WO2021094247A1 (en) 2019-11-15 2021-05-20 KaNDy Therapeutics Limited New chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of nt-814
WO2025242583A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Novel formulation comprising elinzanetant in a solid dispersion
WO2025242585A1 (en) 2024-05-24 2025-11-27 Bayer Consumer Care Ag Crystalline forms of salts of elinzanetant and compositions containing salts of elinzanetant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69728883T2 (de) 1996-07-17 2005-04-07 Merck & Co., Inc. Änderung des zirkadischen rhythmus mit nicht-peptidischen neurokinin-1 rezeptor antagonisten
DK1035115T3 (da) 1999-02-24 2005-01-24 Hoffmann La Roche 4-phenylpyridinderivater og anvendelse deraf som NK-1-receptorantagonister
WO2001030348A1 (en) 1999-10-25 2001-05-03 Janssen Pharmaceutica N.V. Use of substance p antagonists for influencing the circadian timing system
GB0203020D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
GB0203022D0 (en) 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
CN1852712B (zh) 2003-07-03 2010-06-09 弗·哈夫曼-拉罗切有限公司 用于治疗精神分裂症的双重nk1/nk3拮抗剂
JO2722B1 (en) * 2005-09-09 2013-09-15 سميث كلاين بيتشام كوربوريشن New vehicles

Similar Documents

Publication Publication Date Title
JP2011518833A5 (OSRAM)
JP2009149903A5 (OSRAM)
JP2013537203A5 (OSRAM)
JP2009535462A5 (OSRAM)
JP2011529942A5 (OSRAM)
JP2012092103A5 (OSRAM)
JP2020502092A5 (OSRAM)
JP2017514910A5 (OSRAM)
JP2010516681A5 (OSRAM)
JP2011529054A5 (OSRAM)
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
JP2014526533A5 (OSRAM)
JP2015508092A5 (OSRAM)
SMT201700142T1 (it) SALE DI CAMSILATO DI (1r, 1’R, 4R)-4-METOSSI-5’’-METIL-6’-[5-(PROP-1-IN-1-IL)PIRIDIN-3-IL]-3’H-DISPIRO[CICLOESANO-1,2’-INDEN-1’2’-IMIDAZOLO]-4’’-AMMINA E SUE FORME CRISTALLINE PER IL TRATTAMENTO DI PATOLOGIE A[BETA]-CORRELATE COME PER ESEMPIO LA MALATTIA DI ALZHEIMER
JP2016510768A5 (OSRAM)
JP2010534246A5 (OSRAM)
JP2009221198A5 (OSRAM)
JP2013513607A5 (OSRAM)
JP2011515406A5 (OSRAM)
JP2012511558A5 (OSRAM)
JP2011524898A5 (OSRAM)
HRP20220031T1 (hr) Kristalni trihidratni oblik (3s,3s') 4,4'-disulfanedilbis (3-aminobutan 1-sulfonske kiseline)
JP2018009003A5 (OSRAM)
JP2016501844A5 (OSRAM)
JP2014517037A5 (OSRAM)